FMC Corporation has signed a definitive agreement to sell its Epax® Omega-3 business to Pelagia AS. The transaction is expected to close by the end of Q3 2017, subject to customary regulatory approvals and closing conditions.
“We are pleased to sell our Omega-3 business to Pelagia AS, a leading manufacturer of pelagic fish products,” said Eric Norris, president, FMC Health and Nutrition. “We believe Pelagia provides a strong strategic fit for our Epax® Omega-3 product line and will complement Pelagia’s existing portfolio.”
Terms of the transaction were not disclosed.
Source: FMC
ExxonMobil Corp. (Spring, Tex.) announced the startup of two new chemical production units at its Baytown, Texas, manufacturing facility. The $2 billion expansion is part of ExxonMobil’s long-term growth plans to deliver higher-value products from its U.S. Gulf Coast refining and chemical facilities.
Ineos Enterprises has announced the acquisition of Eramet Titanium & Iron (ETI) from Eramet for €230 million ($245 million). The deal was completed on Sept. 21 and takes immediate effect, following the satisfaction of regulatory approvals.
Arxada has appointed Sanjeev Rastogi as Chief Executive Officer (CEO), effective immediately. He succeeds Marc Doyle who led Arxada since its foundation and will join the company’s board of directors as a non-executive member.
